Determining the Effective Sample Size of a Parametric Prior

From MaRDI portal
Publication:3506509

DOI10.1111/j.1541-0420.2007.00888.xzbMath1137.62014OpenAlexW2041098432WikidataQ41871357 ScholiaQ41871357MaRDI QIDQ3506509

Peter Mueller, Peter F. Thall, Satoshi Morita

Publication date: 13 June 2008

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: http://europepmc.org/articles/pmc3081791




Related Items

Robust meta‐analytic‐predictive priors in clinical trials with historical control informationThe Wasserstein impact measure (WIM): a practical tool for quantifying prior impact in Bayesian statisticsMeta-analytic-predictive use of historical variance data for the design and analysis of clinical trialsWeb-based statistical tools for the analysis and design of clinical trials that incorporate historical controlsThe Effective Sample SizeGraphical prior elicitation in univariate modelsEffective sample size for a mixture priorIterated multisource exchangeability models for individualized inference with an application to mobile sensor dataElastic priors to dynamically borrow information from historical data in clinical trialsPrior effective sample size in phase II clinical trials with mixed binary and continuous responsesDICE: A Bayesian model for early dose finding in phase I trials with multiple treatment coursesOptimality of testing procedures for survival data in the nonproportional hazards settingBayesian dose regimen assessment in early phase oncology incorporating pharmacokinetics and pharmacodynamicsA Bayesian Singular Value Decomposition Procedure for Missing Data ImputationThe phoropter method: a stochastic graphical procedure for prior elicitation in univariate data modelsQuantifying observed prior impactOn divergence measures leading to Jeffreys and other reference priorsBayesian dynamic borrowing of historical information with applications to the analysis of large-scale assessmentsBayesian models and decision algorithms for complex early phase clinical trialsRandom-effects meta-analysis of phase I dose-finding studies using stochastic process priorsControl of type I error rates in Bayesian sequential designsBayesian sample size determination for binary regression with a misclassified covariate and no gold standardBorrowing strength and borrowing index for Bayesian hierarchical modelsA phase I-II basket trial design to optimize dose-schedule regimes based on delayed outcomesBayesian hierarchical random-effects meta-analysis and design of phase I clinical trialsInference and Decision Making for 21st-Century Drug Development and Approval



Cites Work